Visscher Stefan, Kruisheer Elize M, Schurink Carolina A M, Lucas Peter J F, Bonten Marc J M
Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands.
J Antimicrob Chemother. 2008 Jul;62(1):184-8. doi: 10.1093/jac/dkn141. Epub 2008 Apr 4.
We previously validated a Bayesian network (BN) model for diagnosing ventilator-associated pneumonia (VAP). Here, we report on the performance of the model to predict microbial causes of VAP and to select antibiotics.
Pathogens were grouped into seven categories based upon the antibiotic susceptibility and epidemiological characteristics. Colonization of the upper respiratory tract was modelled in the BN and depended--in additional steps--on (i) duration of admission and ventilation, (ii) previous culture results and (iii) previous antibiotic use. A database with 153 VAP episodes and their microbial causes was used as reference standard. Appropriateness of antibiotic prescription, with fixed choices for pathogens predicted, was determined.
One hundred and seven VAP episodes were monobacterial and 46 were caused by two pathogens. Using duration of admission and ventilation only, areas under the receiver operating curve (AUC) ranged from 0.511 to 0.772 for different pathogen groups, and model predictions significantly improved when adding information on culture results, but not when adding information on antibiotic use. The best performing model (with all information) had AUC values ranging from 0.859 for Acinetobacter spp. to 0.929 for Streptococcus pneumoniae. With this model, 91 (85%) and 29 (63%) of all pathogen groups were correctly predicted for monobacterial and polymicrobial VAP, respectively. With fixed antibiotic choices linked to pathogen groups, 92% of all episodes would have been treated appropriately.
The BN models' performance to predict pathogens causing VAP improved markedly with information on colonization, resulting in excellent pathogen prediction and antibiotic selection. Prospective external validation is needed.
我们之前验证了一个用于诊断呼吸机相关性肺炎(VAP)的贝叶斯网络(BN)模型。在此,我们报告该模型在预测VAP微生物病因及选择抗生素方面的性能。
根据抗生素敏感性和流行病学特征,将病原体分为七类。在上呼吸道定植情况在BN中进行建模,并在后续步骤中取决于:(i)住院和通气时间;(ii)既往培养结果;(iii)既往抗生素使用情况。以一个包含153例VAP发作及其微生物病因的数据库作为参考标准。确定了针对预测病原体的固定选择的抗生素处方的适宜性。
107例VAP发作由单一细菌引起,46例由两种病原体引起。仅使用住院和通气时间时,不同病原体组的受试者工作特征曲线下面积(AUC)范围为0.511至0.772,添加培养结果信息后模型预测有显著改善,但添加抗生素使用信息时无改善。表现最佳的模型(包含所有信息)的AUC值范围从不动杆菌属的0.859到肺炎链球菌的0.929。使用该模型,单一细菌和多微生物VAP的所有病原体组分别有91例(85%)和29例(63%)被正确预测。对于与病原体组相关的固定抗生素选择,92%的发作可得到恰当治疗。
BN模型在预测引起VAP的病原体方面的性能,随着定植信息的加入有显著改善,从而实现了出色的病原体预测和抗生素选择。需要进行前瞻性外部验证。